390 related articles for article (PubMed ID: 22560049)
21. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
[TBL] [Abstract][Full Text] [Related]
22. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy.
Doppler K; Weis J; Karl K; Ebert S; Ebentheuer J; Trenkwalder C; Klebe S; Volkmann J; Sommer C
Mov Disord; 2015 Oct; 30(12):1688-92. PubMed ID: 26175301
[TBL] [Abstract][Full Text] [Related]
23. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
Zange L; Noack C; Hahn K; Stenzel W; Lipp A
Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
[TBL] [Abstract][Full Text] [Related]
25. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
[TBL] [Abstract][Full Text] [Related]
27. The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson's Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells.
De Luca CMG; Consonni A; Cazzaniga FA; Bistaffa E; Bufano G; Quitarrini G; Celauro L; Legname G; Eleopra R; Baggi F; Giaccone G; Moda F
Cells; 2021 Dec; 11(1):. PubMed ID: 35011649
[TBL] [Abstract][Full Text] [Related]
28. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
[TBL] [Abstract][Full Text] [Related]
29. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.
Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119
[TBL] [Abstract][Full Text] [Related]
30. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
31. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
Armstrong RA; Cairns NJ; Lantos PL
Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
[TBL] [Abstract][Full Text] [Related]
32. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
33. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
Wang Y; Lü C; Ye Z
Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
[TBL] [Abstract][Full Text] [Related]
34. Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
Brumberg J; Kuzkina A; Lapa C; Mammadova S; Buck A; Volkmann J; Sommer C; Isaias IU; Doppler K
Neurobiol Dis; 2021 Jun; 153():105332. PubMed ID: 33722614
[TBL] [Abstract][Full Text] [Related]
35. Activity-dependent secretion of alpha-synuclein by enteric neurons.
Paillusson S; Clairembault T; Biraud M; Neunlist M; Derkinderen P
J Neurochem; 2013 May; 125(4):512-7. PubMed ID: 23278133
[TBL] [Abstract][Full Text] [Related]
36. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
37. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease.
Del Tredici K; Hawkes CH; Ghebremedhin E; Braak H
Acta Neuropathol; 2010 Jun; 119(6):703-13. PubMed ID: 20229352
[TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein binding to rab3a in multiple system atrophy.
Dalfó E; Ferrer I
Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
[TBL] [Abstract][Full Text] [Related]
39. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.
Miki Y; Tomiyama M; Ueno T; Haga R; Nishijima H; Suzuki C; Mori F; Kaimori M; Baba M; Wakabayashi K
Neurosci Lett; 2010 Jan; 469(3):357-9. PubMed ID: 20026177
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of PSP and MSA: a case report and review of the literature.
Uchikado H; DelleDonne A; Uitti R; Dickson DW
Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
